BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 16151014)

  • 1. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
    Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
    Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia.
    Sensken SC; Bode C; Nagarajan M; Peest U; Pabst O; Gräler MH
    J Immunol; 2010 Apr; 184(8):4133-42. PubMed ID: 20220090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. Dietary factors and immunological consequences.
    Hla T
    Science; 2005 Sep; 309(5741):1682-3. PubMed ID: 16150998
    [No Abstract]   [Full Text] [Related]  

  • 4. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
    Sensken SC; Nagarajan M; Bode C; Gräler MH
    J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
    Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
    Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding a way out: lymphocyte egress from lymphoid organs.
    Schwab SR; Cyster JG
    Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
    Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
    Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
    Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate.
    Yu XQ; Kramer J; Moran L; O'Neill E; Nouraldeen A; Oravecz T; Wilson AG
    Xenobiotica; 2010 May; 40(5):350-6. PubMed ID: 20175664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest.
    Gorshkova IA; Wang H; Orbelyan GA; Goya J; Natarajan V; Beiser DG; Vanden Hoek TL; Berdyshev EV
    Life Sci; 2013 Sep; 93(9-11):359-66. PubMed ID: 23892195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
    Sensken SC; Bode C; Gräler MH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C; McHeyzer-Williams MG; Rosen H
    Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H; Zimmermann K; Kleuser B
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake.
    Peest U; Sensken SC; Andréani P; Hänel P; Van Veldhoven PP; Gräler MH
    J Cell Biochem; 2008 Jun; 104(3):756-72. PubMed ID: 18172856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.